Table 2.
Maternal and neonatal outcomes according to the two screening strategies
| Group A | Group B | OR (95%CI) | p-value | aOR (95% CI)a | |
|---|---|---|---|---|---|
| Gestational Diabetes Mellitus | n = 3496 | n = 2555 | |||
| 119 (3.4%) | 416 (16.28%) | 5.51 (4.46–6.81) | < 0.001 | 5.53 (4.48–6.84) | |
| Primary Cesarean section | n = 3135 | n = 2321 | |||
| 386 (12.31%) | 320 (13.79%) | 1.13 (0.97–1.33) | 0.109 | 1.07 (0.91–1.26) | |
| Gestational hypertensive disorders | n = 3496 | n = 2555 | |||
| 101 (2.89%) | 73 (2.86%) | 0.98 (0 .72–1.34) | 0.942 | 0.93 (0.69–1.27) | |
| Preterm birth | n = 3496 | n = 2555 | |||
| 228 (6.52%) | 162 (6.43%) | 0.97 (0.78–1.19) | 0.777 | 0.97 (0 .79–1.2) | |
| 5′ Apgar score < 7 | n = 3489 | n = 2547 | |||
| 76 (2.18%) | 56 (2.2%) | 1.009 (0.71–1.43) | 0.957 | 0.98 (0.69–1.40) | |
| Transfer to NICU | n = 3404 | n = 2547 | |||
| 277 (8.14%) | 208 (8.17%) | 1.003 (0.83–1.21) | 0.968 | 0.97 (0.81–1.18) | |
| Neonatal hypoglycaemia | n = 392 | n = 438 | |||
| 65 (16.58%) | 90 (20.55%) | 1.3 (0.91–1.85) | 0.144 | 1.37 (0.96–1.97) | |
| Shoulder dystocia | n = 3489 | n = 2547 | |||
| 64 (1.83%) | 56 (2.20%) | 1.2 (0.83–1.72) | 0.317 | 1.19 (0.83–1.72) | |
| LGA | n = 3496 | n = 2555 | |||
| 433 (12.39%) | 276 (10.81%) | 0.85 (0.73–1.006) | 0.059 | 0.87 (0.74–1.03) | |
| Macrosomia | n = 3496 | n = 2555 | |||
| 319 (9.12%) | 198 (7.75%) | 0.83 (0 .69–1.006) | 0.059 | 0.85 (0.71–1.03) |
aadjusted for nationality and parity